1. Vanishing white matter disease imaged over 3 years
- Author
-
Nasreen Mahomed and Denny Mathew
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,Childhood ataxia and central nervous system hypomyelination ,Ataxia ,lcsh:R895-920 ,Case Report ,030105 genetics & heredity ,Corpus callosum ,Leukoencephalopathy ,03 medical and health sciences ,0302 clinical medicine ,Cerebrospinal fluid ,Medicine ,Radiology, Nuclear Medicine and imaging ,Spasticity ,Radiological and Ultrasound Technology ,Cerebellar ataxia ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,medicine.disease ,medicine.symptom ,Differential diagnosis ,business ,vanishing white mater ,030217 neurology & neurosurgery - Abstract
Childhood ataxia and central nervous system hypomyelination (CACH), also known as ‘vanishing white matter disease’ (VWM), is a leukoencephalopathy with autosomal recessive inheritance. It is characterised by normal psychomotor development initially, with an onset of neurological deterioration that follows a chronic and progressive course. Stress conditions such as febrile infections, minor head trauma or even acute fright provoke major episodes of neurological deterioration. We present a case of a 2-year-old child who presented with spasticity and cerebellar ataxia. After magnetic resonance imaging (MRI) of the brain, CACH/ VWM was diagnosed on the basis of the typical clinical and MRI findings. As there is no known cure for CACH/VWM, our patient was followed up over 3 years with MRIs of the brain to assess the progressive involvement of the cerebral white matter. In those patients with suggestive or inconclusive MRI findings for CACH/VWM, particularly in the presymptomatic stage and adult onset variants, involvement of the inner rim of the corpus callosum should prompt the inclusion of CACH/VWM in the differential diagnosis. Biochemical markers such as the asialotransferrin: transferrin ratio in the cerebrospinal fluid can also potentially be used as a screening tool in this subset of patients prior to gene mutation analysis.
- Published
- 2019